AKU Society led a project to start clinical trials on repurposing an existing medication to a rare disease. “It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU)”. The project started in 2003 and got European Commission’s funding in order to develop and run the clinical trials. The project is ongoing until 2019.
- Geographic focus
- 2 Initiatives